Troubled-Desire & Therapeutic Chat for Reduction of CSAM Use (TD-CHAT)
Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Feb 24, 2025
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
The TD-CHAT trial is a study that aims to help individuals reduce their use of Child Sexual Abuse Material (CSAM) through two types of support: a Therapist Chat Service (TCS) and a Selfhelp Platform. The study focuses on adults, mainly men, who have shown a sexual interest in children and have either recently used CSAM or are at risk. Participants will be assigned to different groups to see which type of support is most effective in decreasing CSAM behaviors and improving overall well-being.
To be eligible for this trial, participants must be at least 18 years old, have used CSAM in the last two weeks or have a past history of use, and be able to understand English, German, or Spanish. They will receive online self-help modules and may also chat with trained therapists. It’s important to note that individuals with severe mental health issues, a history of committing child sexual abuse, or who are currently involved in legal issues related to this matter will not be eligible for the study. The trial is not yet recruiting participants, but it aims to provide valuable support for those looking to change their behavior.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult participant (≥18 years);
- • recent (last 2 weeks) CSAM use or past CSAM use and self-reported risk;
- • proficiency in English, German or Spanish;
- • voluntary participation and agreement to the terms of the study.
- Exclusion Criteria:
- • Severe neuropsychiatric comorbidities (unstable psychotic disorder, organic brain damage, diminished intellectual functioning, untreated drug or alcohol addiction);
- • history of contact CSA perpetration (past or present);
- • ongoing criminal investigation, trial, punishment, or probation status for online or offline CSA or CSAM use;
- • current inpatient psychiatric treatment or other concurrent treatment targeting CSAM behaviours
About Charite University, Berlin, Germany
Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berlin, , Germany
Barcelona, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported